Latest filing published 29 Sept 2025 for Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.), €33k.
All filings by Benoit Gravel on record concern Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.). Between 18 November 2022 and 25 September 2025, the trades on record add up to 5 filings.
The open-market record is one-sided, with 1 purchase worth €3,731 and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 4 option exercises.
The latest filing, published on 29 September 2025, reports an option exercise of €33k in Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.). The last insider purchase was made public on 13 February 2024, 984 days ago. Between a trade and the moment it shows up on SEDI, the median delay is 3 days. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations